Edition:
United Kingdom

ArQule announces $9.5 mln private placement of preferred stock


Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - ArQule Inc :ArQule announces $9.5 million private placement of preferred stock.ArQule Inc - to use proceeds to advance clinical trials related to proprietary pipeline, including derazantinib, miransertib, ARQ 531 & ARQ 751​. 

Company Quote

9.2
-0.34 -3.56%
23 Aug 2019